Advertisement
Loading...

Orgenesis Inc.

ORGS•NASDAQ
Healthcare
Biotechnology
$0.002
$-0.04(-95.29%)
U.S. Market opens in 15h 32m

Orgenesis Inc. (ORGS) Stock Overview

Explore Orgenesis Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap4.1M
P/E Ratio-0.44
EPS (TTM)$-24.46
ROE-16.83%
Fundamental Analysis

AI Price Forecasts

1 Month$-0.16
3 Months$0.25
1 Year Target$0.00

ORGS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Orgenesis Inc. (ORGS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.27, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.44 and a market capitalization of 4.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1602.36%
5-Day Change
138.92%
1-Month Change
32.72%
3-Month Change
44.55%
6-Month Change
278.57%
Year-to-Date (YTD) Change
430.00%
1-Year Change
-57.94%
3-Year Change
-92.57%
5-Year Change
-98.43%
All-Time (Max) Change
-99.56%

Contact Information

https://www.orgenesis.com
480 659 6404
20271 Goldenrod Lane, Germantown, MD, 20876

Company Facts

1,460 Employees
IPO DateMar 13, 2012
CountryUS
Actively Trading

Frequently Asked Questions